دوره 11، شماره 4 - ( 8-1402 )
جلد 11 شماره 4 صفحات 0-0 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mojarad-Jabali S, Molavipordanjani S. Clinical Application of Actinium-225 Radiopharmaceuticals in Targeted Alpha Therapy. Res Mol Med (RMM) 2023; 11 (4)
URL: http://rmm.mazums.ac.ir/article-1-553-fa.html
URL: http://rmm.mazums.ac.ir/article-1-553-fa.html
Clinical Application of Actinium-225 Radiopharmaceuticals in Targeted Alpha Therapy. Research in Molecular Medicine. 1402; 11 (4)
چکیده: (851 مشاهده)
Among the vast variety of radionuclides available, a handful of them possess proper features for targeted alpha therapy (TAT). TAT holds the promise of exceeding the effectiveness of conventional radiotherapy methods. Actinium-225 is considered to be an outstanding isotope for TAT in the management of cancer due to its half-life, which enables sustained delivery at the tumor site. This review covers the clinical applications of actinium-225 radiopharmaceuticals.
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
